Pre-Clinical (Discovery and Development)

Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
 

Introducing The New Molecular Scissors - CRISPR & Cas9

Contributor: Chanice Henry
Posted: 8/3/2015

Introducing The New Molecular Scissors - CRISPR & Cas9 - Chanice Henry

The CRISPR tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing. CRISPR alongside the use of the Cas9 protein enables the ability to target a specific section of a gene sequence and edit it – by deleting and sometimes replacing the function with a new element. Full Article »


Events related to this topic:

Utilising Big Data for Bioscience Product Development

Contributor: Diana Davis
Posted: 7/3/2014


Utilising Big Data for Bioscience Product Development - Diana Davis

Big data is turning up everywhere. In this Process Perspectives podcast, Kaare Buch Petersen, Information Architect in Global IT at Christen Hansen, a Denmark-based supplier of bioscience products to food and health industries, talks about how his company has been using big data in the development of their new products. Full Podcast »


Events related to this topic:

The Rocky Road to Success

Contributor: Tony Hitchcock
Posted: 6/3/2015


The Rocky Road to Success - Tony Hitchcock

Having worked in the development and production of early stage therapeutics for over 30 years I appreciate as much as anyone that this is often a highly challenging environment, not least with regards to overcoming technical and regulatory hurdles as well as seeking to meet a highly demanding timeline. Full Column »


Events related to this topic:

Making the Future of the Lab Today's Reality

We’re all aware that the way research and development (R&D) is carried out today represents a huge change compared to a few years ago. With concepts such as ‘the lab of the future’ and the ‘paperless lab’ becoming more common, it’s important to understand what these terms really mean in practice. In this paper, we’ll be examining what the future holds and also the main drivers pushing the industry towards new ways of working. And just as R&D-focused organizations have had to adapt, we’ll conclude by examining the response of the R&D enterprise software sector to the challenges of change. Pharma IQ partner IDBS explores the concept of bringing the lab of the future into today's market. Find out how R&D is changing, why, and what this means for R&D enterprise technology. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community